Thrombosis
Conference Coverage
DETOUR system shows early promise for long SFA lesions
Percutaneous treatment of long SFA lesions showed good patency, low rate of major adverse events.
News
Genotype-guided warfarin appears safer
Genotype-guided warfarin dosing is safer than clinically guided dosing for patients undergoing elective hip or knee arthroplasty, according to a...
Conference Coverage
IN.PACT Global: Promising 2-year data for drug-coated balloon performance for femoropopliteal PAD
Drug-coated balloon shows promising 2-year results for treating fempop PAD.
News
ESC working groups publish consensus on DVT
Experts in Europe have published a consensus document on the diagnosis and management of acute deep vein thrombosis (DVT). The document provides...
Conference Coverage
VIDEO: Educational intervention boosts A fib anticoagulation
BARCELONA – Patient education and feedback increased anticoagulation and cut strokes.
News
EMA issues final opinion on FVIII products
The European Medicines Agency (EMA) has concluded there is “no clear and consistent evidence” of a difference in inhibitor development between the...
News
Synthetic heparin poised for clinical trials, team says
Researchers say they have synthesized low molecular weight heparin (LMWH) that may someday replace animal-sourced heparin. The team created...
Feature
Absorb bioresorbable scaffold folds
Abbott is no longer marketing the Absorb bioresorbable scaffold, citing poor sales.
News
Death prompts dosing suspension in fitusiran trials
Alnylam Pharmaceuticals, Inc.
News
Height is independent predictor of VTE
Taller individuals have an increased risk of venous thromboembolism (VTE), according to research published in Circulation: Cardiovascular Genetics...
News
Anticoagulant prompts weight gain in mice
Researchers say they have discovered a novel role for heparin as a promoter of food intake and weight gain in animal models. The team’s findings...